Skip to main content

Reaching out!

I’m so excited I could just bust. For two years I’ve been reading about people with Hermansky-Pudlak Syndrome in Japan in the medical literature. Several years ago I found an article in a Chinese journal that made reference to 300 people with HPS in Japan in the abstract. The abstract, however, was the only part of the article that was translated into English. I e-mailed the author to ask how he knew about these 300 patients, and never got an answer.

Then two years ago I read another journal article by a doctor in Japan that said in the abstract that HPS was the second most common type of albinism in Japan. Again, I e-mailed and never got an answer.

It’s been bugging me for years. Somewhere in Japan I knew there were people with HPS, but I had no way to reach out and find them. Were they organized? Did they know they had HPS? While HPS is rare in Japan as well, there are clearly more than two or three people affected there.

So, every few months I’ve surveyed the internet for HPS medical journal articles by doctors in Japan, then tracked down the doctors’ e-mails and hoped that one day someone would answer me and tell me about this group of people with HPS.

While I was away at ATS one of the doctors finally answered. He sent an e-mail in perfect English confirming that there are indeed a number of people with HPS in Japan, and they’ve got their own patient organization! The scary thing is I almost missed the e-mail completely in the several hundred I got while I was away. I almost deleted it!

I sent the information to Donna. She immediately sent an e-mail to their director. We’re waiting to hear back. I can hardly stand it. I knew they were there!

Comments

Care said…
Wow - great job researching and reaching out!

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria